CHANGSHACHIBEIJIANZHINENGKEJIYOUXIANGONGSI – Trademark Portfolio

Entity Type: 16

CHANGSHACHIBEIJIANZHINENGKEJIYOUXIANGONGSI holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include DENTIMICA. The owner is based in Changsha, Hunan.

Gaoxin District, Xincheng Kejiyuan

Rm 1002A, Bldg. 14, Qingshan Rd 662

Changsha, Hunan 410000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DENTIMICA
DENTIMICA
Registered 2023

Trademark Classifications

CHANGSHACHIBEIJIANZHINENGKEJIYOUXIANGONGSI's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does CHANGSHACHIBEIJIANZHINENGKEJIYOUXIANGONGSI have?

CHANGSHACHIBEIJIANZHINENGKEJIYOUXIANGONGSI has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does CHANGSHACHIBEIJIANZHINENGKEJIYOUXIANGONGSI file in?

CHANGSHACHIBEIJIANZHINENGKEJIYOUXIANGONGSI files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are CHANGSHACHIBEIJIANZHINENGKEJIYOUXIANGONGSI's most well-known trademarks?

CHANGSHACHIBEIJIANZHINENGKEJIYOUXIANGONGSI's registered trademark portfolio includes well-known marks such as DENTIMICA. These are among 1 currently registered trademark in the portfolio.

What is CHANGSHACHIBEIJIANZHINENGKEJIYOUXIANGONGSI's trademark registration success rate?

CHANGSHACHIBEIJIANZHINENGKEJIYOUXIANGONGSI has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.